Pluristem Therapeutics Inc. (Nasdaq: PSTI) increased its previously announced bought deal to $15 million. The stock price fell 25 cents to close at $1.15.
Pluristem Therapeutics increases bought deal
January 20, 2017 at 16:14 PM EST
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|